297 related articles for article (PubMed ID: 34427338)
1. Preexisting Bipolar Disorder Influences the Subsequent Phenotype of Parkinson's Disease.
Onofrj M; Di Iorio A; Carrarini C; Russo M; Franciotti R; Espay AJ; Boylan LS; Taylor JP; Di Giannantonio M; Martinotti G; Valente EM; Thomas A; Bonanni L; Delli Pizzi S; Dono F; Sensi S
Mov Disord; 2021 Dec; 36(12):2840-2852. PubMed ID: 34427338
[TBL] [Abstract][Full Text] [Related]
2. Early cognitive decline after bilateral subthalamic deep brain stimulation in Parkinson's disease patients with GBA mutations.
Mangone G; Bekadar S; Cormier-Dequaire F; Tahiri K; Welaratne A; Czernecki V; Pineau F; Karachi C; Castrioto A; Durif F; Tranchant C; Devos D; Thobois S; Meissner WG; Navarro MS; Cornu P; Lesage S; Brice A; Welter ML; Corvol JC;
Parkinsonism Relat Disord; 2020 Jul; 76():56-62. PubMed ID: 32866938
[TBL] [Abstract][Full Text] [Related]
3. The Genetic Etiology of Parkinson's Disease Does Not Robustly Affect Subthalamic Physiology.
Weill C; Gallant A; Baker Erdman H; Abu Snineh M; Linetsky E; Bergman H; Israel Z; Arkadir D
Mov Disord; 2023 Mar; 38(3):484-489. PubMed ID: 36621944
[TBL] [Abstract][Full Text] [Related]
4. GBA-Associated Parkinson's Disease: Progression in a Deep Brain Stimulation Cohort.
Lythe V; Athauda D; Foley J; Mencacci NE; Jahanshahi M; Cipolotti L; Hyam J; Zrinzo L; Hariz M; Hardy J; Limousin P; Foltynie T
J Parkinsons Dis; 2017; 7(4):635-644. PubMed ID: 28777757
[TBL] [Abstract][Full Text] [Related]
5. Elevated Mood States in Patients With Parkinson's Disease Treated With Deep Brain Stimulation: Diagnosis and Management Strategies.
Seritan AL; Spiegel LL; Weinstein JL; Racine CA; Brown EG; Volz M; de Hemptinne C; Starr PA; Ostrem JL
J Neuropsychiatry Clin Neurosci; 2021; 33(4):314-320. PubMed ID: 34213980
[TBL] [Abstract][Full Text] [Related]
6. Predictors of the emergence of apathy after bilateral stimulation of the subthalamic nucleus in patients with Parkinson's disease.
Higuchi MA; Tsuboi Y; Inoue T; Fukuyama K; Abe H; Baba Y; Yamada T
Neuromodulation; 2015 Feb; 18(2):113-7. PubMed ID: 24799286
[TBL] [Abstract][Full Text] [Related]
7. Subthalamic nucleus stimulation does not cause deterioration of preexisting hallucinations in Parkinson's disease patients.
Yoshida F; Miyagi Y; Kishimoto J; Morioka T; Murakami N; Hashiguchi K; Samura K; Sakae N; Yamasaki R; Kawaguchi M; Sasaki T
Stereotact Funct Neurosurg; 2009; 87(1):45-9. PubMed ID: 19174620
[TBL] [Abstract][Full Text] [Related]
8. Bilateral subthalamic deep brain stimulation initial impact on nonmotor and motor symptoms in Parkinson's disease: An open prospective single institution study.
Kurcova S; Bardon J; Vastik M; Vecerkova M; Frolova M; Hvizdosova L; Nevrly M; Mensikova K; Otruba P; Krahulik D; Kurca E; Sivak S; Zapletalova J; Kanovsky P
Medicine (Baltimore); 2018 Feb; 97(5):e9750. PubMed ID: 29384860
[TBL] [Abstract][Full Text] [Related]
9. Longterm outcome of cognition, affective state, and quality of life following subthalamic deep brain stimulation in Parkinson's disease.
Gruber D; Calmbach L; Kühn AA; Krause P; Kopp UA; Schneider GH; Kupsch A
J Neural Transm (Vienna); 2019 Mar; 126(3):309-318. PubMed ID: 30684055
[TBL] [Abstract][Full Text] [Related]
10. Association of Subthalamic Deep Brain Stimulation With Motor, Functional, and Pharmacologic Outcomes in Patients With Monogenic Parkinson Disease: A Systematic Review and Meta-analysis.
Artusi CA; Dwivedi AK; Romagnolo A; Pal G; Kauffman M; Mata I; Patel D; Vizcarra JA; Duker A; Marsili L; Cheeran B; Woo D; Contarino MF; Verhagen L; Lopiano L; Espay AJ; Fasano A; Merola A
JAMA Netw Open; 2019 Feb; 2(2):e187800. PubMed ID: 30707228
[TBL] [Abstract][Full Text] [Related]
11. Subthalamic deep brain stimulation aggravates speech problems in Parkinson's disease: Objective and subjective analysis of the influence of stimulation frequency and electrode contact location.
Phokaewvarangkul O; Boonpang K; Bhidayasiri R
Parkinsonism Relat Disord; 2019 Sep; 66():110-116. PubMed ID: 31327627
[TBL] [Abstract][Full Text] [Related]
12. Characteristic laryngoscopic findings in Parkinson's disease patients after subthalamic nucleus deep brain stimulation and its correlation with voice disorder.
Tsuboi T; Watanabe H; Tanaka Y; Ohdake R; Yoneyama N; Hara K; Ito M; Hirayama M; Yamamoto M; Fujimoto Y; Kajita Y; Wakabayashi T; Sobue G
J Neural Transm (Vienna); 2015 Dec; 122(12):1663-72. PubMed ID: 26254905
[TBL] [Abstract][Full Text] [Related]
13. The Contribution of Subthalamic Nucleus Deep Brain Stimulation to the Improvement in Motor Functions and Quality of Life.
Tödt I; Al-Fatly B; Granert O; Kühn AA; Krack P; Rau J; Timmermann L; Schnitzler A; Paschen S; Helmers AK; Hartmann A; Bardinet E; Schuepbach M; Barbe MT; Dembek TA; Fraix V; Kübler D; Brefel-Courbon C; Gharabaghi A; Wojtecki L; Pinsker MO; Thobois S; Damier P; Witjas T; Houeto JL; Schade-Brittinger C; Vidailhet M; Horn A; Deuschl G
Mov Disord; 2022 Feb; 37(2):291-301. PubMed ID: 35112384
[TBL] [Abstract][Full Text] [Related]
14. Do patient's get angrier following STN, GPi, and thalamic deep brain stimulation.
Burdick AP; Foote KD; Wu S; Bowers D; Zeilman P; Jacobson CE; Ward HE; Okun MS
Neuroimage; 2011 Jan; 54 Suppl 1():S227-32. PubMed ID: 20932923
[TBL] [Abstract][Full Text] [Related]
15. The LRRK2 G2019S mutation status does not affect the outcome of subthalamic stimulation in patients with Parkinson's disease.
Greenbaum L; Israeli-Korn SD; Cohen OS; Elincx-Benizri S; Yahalom G; Kozlova E; Strauss H; Molshatzki N; Inzelberg R; Spiegelmann R; Israel Z; Hassin-Baer S
Parkinsonism Relat Disord; 2013 Nov; 19(11):1053-6. PubMed ID: 23932063
[TBL] [Abstract][Full Text] [Related]
16. Nonmotor symptoms evolution during 24 months of bilateral subthalamic stimulation in Parkinson's disease.
Dafsari HS; Silverdale M; Strack M; Rizos A; Ashkan K; Mahlstedt P; Sachse L; Steffen J; Dembek TA; Visser-Vandewalle V; Evans J; Antonini A; Martinez-Martin P; Ray-Chaudhuri K; Timmermann L;
Mov Disord; 2018 Mar; 33(3):421-430. PubMed ID: 29465787
[TBL] [Abstract][Full Text] [Related]
17. GBA Variants in Parkinson's Disease: Clinical, Metabolomic, and Multimodal Neuroimaging Phenotypes.
Greuel A; Trezzi JP; Glaab E; Ruppert MC; Maier F; Jäger C; Hodak Z; Lohmann K; Ma Y; Eidelberg D; Timmermann L; Hiller K; Tittgemeyer M; Drzezga A; Diederich N; Eggers C
Mov Disord; 2020 Dec; 35(12):2201-2210. PubMed ID: 32853481
[TBL] [Abstract][Full Text] [Related]
18. Impact of Subthalamic Deep Brain Stimulation on Impulse Control Disorders in Parkinson's Disease: A Prospective Study.
Santin MDN; Voulleminot P; Vrillon A; Hainque E; Béreau M; Lagha-Boukbiza O; Wirth T; Montaut S; Bardinet E; Kyheng M; Rolland AS; Voirin J; Drapier S; Durif F; Eusebio A; Giordana C; Auzou N; Houeto JL; Hubsch C; Jarraya B; Laurencin C; Maltete D; Meyer M; Rascol O; Rouaud T; Tir M; Moreau C; Corvol JC; Proust F; Grabli D; Devos D; Tranchant C; Anheim M;
Mov Disord; 2021 Mar; 36(3):750-757. PubMed ID: 33022101
[TBL] [Abstract][Full Text] [Related]
19. Distinct phenotypes of speech and voice disorders in Parkinson's disease after subthalamic nucleus deep brain stimulation.
Tsuboi T; Watanabe H; Tanaka Y; Ohdake R; Yoneyama N; Hara K; Nakamura R; Watanabe H; Senda J; Atsuta N; Ito M; Hirayama M; Yamamoto M; Fujimoto Y; Kajita Y; Wakabayashi T; Sobue G
J Neurol Neurosurg Psychiatry; 2015 Aug; 86(8):856-64. PubMed ID: 25280914
[TBL] [Abstract][Full Text] [Related]
20. Effects of deep brain stimulation of the subthalamic nucleus on freezing of gait in Parkinson's disease: a prospective controlled study.
Vercruysse S; Vandenberghe W; Münks L; Nuttin B; Devos H; Nieuwboer A
J Neurol Neurosurg Psychiatry; 2014 Aug; 85(8):871-7. PubMed ID: 24396010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
